ITALO BIAGGIONI, MD
Osteopathic Medicine in Nashville, TN
License number
Tennessee MD17766
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Tennessee MD17766
Category
Osteopathic Medicine
Type
Clinical Pharmacology
Address
Address
3601 Tvc, Nashville, TN 37232
Phone
(615) 322-3000
Organization information
See more information about ITALO BIAGGIONI at bizstanding.comItalo Biaggioni MD
719 Thompson Ln, Nashville, TN 37204
Industry:
Internist
Phone:
(615) 322-3000 (Phone)
Italo O. Biaggioni
Vanderbilt Heart Vascular Institute - Italo Biaggioni MD
1215 21 Ave S #5209, Nashville, TN 37232
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Phone:
(615) 322-2318 (Phone)
Professional information
Professor At Vanderbilt University
Position:
Professor at Vanderbilt University
Location:
Greater Nashville Area
Industry:
Higher Education
Work:
Vanderbilt University
-
Professor
Italo O Biaggioni, Nashville TN
Specialties:
Internal Medicine, Cardiovascular Disease, Clinical Pharmacology, General Practice, Physical Medicine & Rehabilitation
Work:
Vanderbilt Health 100 Oaks
719 Thompson Ln, Nashville, TN 37204 Vanderbilt Cardiology Group
3601 The Vanderbilt Clinic, Nashville, TN 37232
719 Thompson Ln, Nashville, TN 37204 Vanderbilt Cardiology Group
3601 The Vanderbilt Clinic, Nashville, TN 37232
Education:
Universidad Peruana Cayetano Heredia (1980)
Dr. Italo Biaggioni - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Languages:
English
Hospitals:
Vanderbilt Heart and Vascular Institute
1215 21St Ave S, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
Vanderbilt Heart and Vascular Institute
1215 21St Ave S, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
1215 21St Ave S, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
Vanderbilt Heart and Vascular Institute
1215 21St Ave S, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
Education:
Medical School
Universidad Peruana Cayetano Heredia, Facultad De Medicina Alberto Hurtado
Graduated: 1980
Universidad Peruana Cayetano Heredia, Facultad De Medicina Alberto Hurtado
Graduated: 1980
Selective Antagonists Of A2B Adenosine Receptors
US Patent:
6815446, Nov 9, 2004
Filed:
Aug 28, 2000
Appl. No.:
09/648775
Inventors:
Italo O. Biaggioni - Nashville TN
Igor A. Feoktistov - Nashville TN
Jack N. Wells - Nashville TN
Igor A. Feoktistov - Nashville TN
Jack N. Wells - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
C07D47306
US Classification:
5142632, 5142342, 51426334, 51426322, 544272, 544118
Abstract:
A compound of the following formula: wherein R is an aliphatic or cycloaliphatic amine group or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable salt thereof. The compounds of formula (I) may be used to treat, among other indications, asthma and diarrhea.
Use Of Adenosine Receptor Ligands To Promote Cell Adhesion In Cell-Based Therapies
US Patent:
2009013, May 28, 2009
Filed:
Jul 10, 2008
Appl. No.:
12/170883
Inventors:
Italo Biaggioni - Nashville TN, US
Igor Feoktistov - Nashville TN, US
Antonis K. Hatzopoulos - Nashville TN, US
Sergey Ryzhov - Nashville TN, US
Douglas E. Vaughan - Chicago IL, US
Igor Feoktistov - Nashville TN, US
Antonis K. Hatzopoulos - Nashville TN, US
Sergey Ryzhov - Nashville TN, US
Douglas E. Vaughan - Chicago IL, US
International Classification:
A61K 35/12
US Classification:
424 937
Abstract:
Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging concept for the treatment of cardiovascular disease, and enhancement of EPC adhesion to vascular endothelium should improve cell retention within targeted organs, as well as vascular development. The present inventors have shown that stimulation of adenosine receptors (AdoR) in murine embryonic EPCs (eEPCs) and cardiac endothelial cells (cECs) rapidly, within minutes, increased eEPC adhesion to cECs. eEPCs and cECs were found to predominantly express functional Aand AAdoR subtypes, respectively, and both subtypes are involved in the regulation of eEPC adhesion to cECs. Adenosine, adenosine precursors (e.g., AMP) and adenosine receptor agonists thus can be used to stimulate EPC/stem cell homing and engraftment in cell-based therapies.
Selective Antagonists Of A2B Adenosine Receptors
US Patent:
2003008, May 8, 2003
Filed:
Nov 1, 2002
Appl. No.:
10/285747
Inventors:
Italo Biaggioni - Nashville TN, US
Igor Feoktistov - Nashville TN, US
Jack Wells - Nashville TN, US
Igor Feoktistov - Nashville TN, US
Jack Wells - Nashville TN, US
Assignee:
Vanderbilt University
International Classification:
A61K031/5377, A61K031/522, C07D473/04
US Classification:
514/234500, 514/252160, 514/263200, 514/263220, 514/263340, 544/118000, 544/272000, 544/267000
Abstract:
A compound of the following formula:
wherein R is an aliphatic or cycloaliphatic amine group or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable salt thereof. The compounds of formula (I) may be used to treat, among other indications, asthma and diarrhea.
Methods Of Inducing Vasodilation
US Patent:
2006007, Apr 13, 2006
Filed:
Sep 14, 2005
Appl. No.:
11/226626
Inventors:
Italo Biaggioni - Nashville TN, US
International Classification:
A61K 31/7076
US Classification:
514047000
Abstract:
Provided herein are methods of inducing vasodilation in a subject diagnosed with a need for vasodilation, comprising administering into a blood vessel of the subject a therapeutically effective amount of a composition consisting essentially of adenosine monophosphate in a pharmaceutically acceptable carrier, whereby the administration of the composition induces vasodilation in the subject. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.